Nephros (NEPH) SEC Filings & 10K Form

$2.09
-0.01 (-0.48%)
(As of 04/22/2024 ET)

Recent Nephros SEC Filings

DateFilerForm TypeView
04/12/2024
3:10 PM
Nephros (Filer)
Form ARS
04/12/2024
3:10 PM
Nephros (Filer)
Form ARS
03/14/2024
3:43 PM
DAVIDSON CHARLES E (Reporting)
JACOBS JOSEPH (Reporting)
Nephros (Issuer)
WEXFORD CAPITAL LP (Reporting)
Wexford GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:48 PM
Nephros (Issuer)
Spandow Oliver J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:47 PM
Amron Arthur H (Reporting)
Nephros (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:48 PM
Harris Joseph Michael (Reporting)
Nephros (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:48 PM
Lask Alisa (Reporting)
Nephros (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:17 PM
Banks Robert R. Jr. (Reporting)
Nephros (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
3:05 PM
Nephros (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
3:29 PM
Krandel Judy (Reporting)
Nephros (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/10/2023
3:07 PM
Nephros (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NEPH) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners